Measurement of Serum Free Thyroxine Index May Provide Additional Case Detection Compared to Free Thyroxine in the Diagnosis of Central Hypothyroidism

by Pantalone, Kevin M., Hatipoglu, Betul, Gupta, Manjula K., Kennedy, Laurence, Hamrahian, Amir H.
Published 2015

Thyrotoxicosis with absence of clinical features of acromegaly in a TSH- and GH-secreting, invasive pituitary macroadenoma

by Johnston, Philip C, Hamrahian, Amir H, Prayson, Richard A, Kennedy, Laurence, Weil, Robert J
Published 2015

Surgical management of recurrent Cushing's disease in pregnancy: A case report

by Abbassy, Mahmoud, Kshettry, Varun R., Hamrahian, Amir H., Johnston, Philip C., Dobri, Georgianna A., Avitsian, Rafi, Woodard, Troy D., Recinos, Pablo F.
Published 2015

A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone–Deficient Adults

by Yuen, Kevin C. J., Conway, Gerard S., Popovic, Vera, Merriam, George R., Bailey, Timothy, Hamrahian, Amir H., Biller, Beverly M. K., Kipnes, Mark, Moore, Jerome A., Humphriss, Eric, Bright, George M., Cleland, Jeffrey L.
Published 2013

Osilodrostat, a potent oral 11β-hydroxylase inhibitor: 22-week, prospective, Phase II study in Cushing’s disease

by Fleseriu, Maria, Pivonello, Rosario, Young, Jacques, Hamrahian, Amir H., Molitch, Mark E., Shimizu, Chikara, Tanaka, Tomoaki, Shimatsu, Akira, White, Tracy, Hilliard, Annie, Tian, Chuan, Sauter, Nicholas, Biller, Beverly MK, Bertagna, Xavier
Published 2015